Ocugen, Inc. - Common Stock (NQ:OCGN)

1.020 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

36 37 Next >

3 Biotech Stocks That Have More Than Tripled so far This Year ↗

November 18, 2021

But can they keep up the momentum?

Via The Motley Fool

2 More Stocks Set to 2x… 5x… 10x in 2022 ↗

November 17, 2021

Finding 10x stocks is possible; it's simply a matter of knowing what patterns to look for. Here are a couple of strong contenders.

Via InvestorPlace

Topics Economy

3 Things About Ocugen That Smart Investors Know ↗

November 17, 2021

Revenue may not be right around the corner.

Via The Motley Fool

Ocugen Proves Groupthink Is a Double-Edged Sword ↗

November 17, 2021

While OCGN stock is an intriguing idea on the science, when the masses have a different framework, it becomes a risky proposition.

Via InvestorPlace

Ocugen Needs More Than Covaxin to Boost Its Falling Shares ↗

November 16, 2021

A doomed-looking vaccine partnership puts Ocugen back in the business of obscurity and OCGN stock at risk of much lower prices.

Via InvestorPlace

As OCGN Stock Trudges Along Without Real Hope Must Wane ↗

November 16, 2021

Ocugen is nothing but false hope despite positive news

Via InvestorPlace

Here's What Needs to Happen for Ocugen Stock to Be a Screaming Buy ↗

November 12, 2021

The company needs clear regulatory wins in the U.S. and Canada.

Via The Motley Fool

Is Ocugen About to Beat Moderna in This One Market? ↗

November 12, 2021

Ocugen aims to be among the first to carve out market share.

Via The Motley Fool

WHO’s Nod Can’t Mask Ocugen’s Flimsy Fundamentals ↗

November 11, 2021

Ocugen has been trying to commercialize a Covid-19 vaccine. However, it's facing many obstacles. Meanwhile, insiders are dumping OCGN stock.

Via InvestorPlace

7 Stocks To Sell Before They Head to The Market Graveyard ↗

November 11, 2021

So, which ones are stocks to sell ASAP? With these seven stocks, all former favorites on both Main Street and Wall Street, consider it high time to take the money and run.

Via InvestorPlace

Does Ocugen Have a Shot at Winning EUA for Its COVID Vaccine in Kids? ↗

November 10, 2021

Yes -- but the odds don't look great.

Via The Motley Fool

Ocugen, Inc. (OCGN) Q3 2021 Earnings Call Transcript ↗

November 09, 2021

OCGN earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

OCGN Stock Alert: The Earnings News That Has Ocugen Slipping Today ↗

November 09, 2021

OCGN stock is pulling back after a muted earnings report this morning, as Ocugen makes a big bet on Covaxin for kids.

Via InvestorPlace

7 Meme Stocks Ready to Regain Their Lost Momentum ↗

November 09, 2021

Aggressive investors looking to profit off of the recent impressive volatility in certain companies may want to consider these meme stocks.

Via InvestorPlace

2 Moonshots That Insiders Are Buying… and 3 They’re Not ↗

November 09, 2021

The first several days of November saw insiders spend nearly $750 million buying up shares of their companies, which is worth your attention.

Via InvestorPlace

Sell-the-News Moment Is Your Chance to Reload on Ocugen ↗

November 09, 2021

Even as OCGN stock moves backward, Ocugen's moving forward with a crucial approval

Via InvestorPlace

Where Will Ocugen Be in 3 Years? ↗

November 08, 2021

Most likely in the doldrums, but it could be temporary.

Via The Motley Fool

Ocugen Stock Looks Poised to Take a Tumble Right Here ↗

November 08, 2021

After WHO granted Covaxin a limited Emergency Use Listing, many institutions and hedge funds are likely to sell or short OCGN stock.

Via InvestorPlace

Is Ocugen a Buy? ↗

November 07, 2021

It'll take more than regulatory approvals of its vaccine for it to become a good investment.

Via The Motley Fool

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗

November 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...

Via Benzinga

Ocugen Seeks FDA Emergency Use Nod For Covaxin COVID-19 Vaccine In Kids ↗

November 05, 2021

Ocugen Inc (NASDAQ: OCGN) said that it sent a request to the FDA for an emergency authorization for its COVID-19 vaccine candidate BBV152, known as Covaxin outside...

Via Benzinga

With Ocugen Stock: Follow The Lead of Traders and ‘Sell The News’ ↗

November 05, 2021

WHO approval for Covaxin doesn't change the game much for OCGN stock, steer clear as it slides back to lower prices.

Via InvestorPlace

Here's Why Shares of Moderna, Novavax, and Ocugen Have All Been Extremely Volatile This Week ↗

November 05, 2021

Multiple earnings reports and regulatory updates shook up the coronavirus vaccine space this week.

Via The Motley Fool

The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill ↗

November 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus NRx's COVID-19 Drug Fails to Get Authorization From FDA Due To...

Via Benzinga

This Surprising FDA Announcement Could Be Huge for Ocugen ↗

November 05, 2021

The agency will allow vaccine boosters to be mixed and matched.

Via The Motley Fool

Is Ocugen's Surge Much Ado About Nothing? ↗

November 05, 2021

The short answer: Yes.

Via The Motley Fool

81 Biggest Movers From Yesterday ↗

November 05, 2021

Gainers Evaxion Biotech A/S (NASDAQ: EVAX) shares jumped 95.1% to close at $12.68 on Thursday after dropping over 10% on Wednesday. TDH Holdings, Inc. (NASDAQ: PETZ) jumped 79.8...

Via Benzinga

Avoid Ocugen — The Vaccine Is Too Little, Too Late ↗

November 04, 2021

With high percentage of vaccination in U.S. and Canada, Ocugen has a limited addressable market. Limited cash flow visibility from vaccine. With the company still waiting for official FDA approval for...

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 04, 2021

Gainers Evaxion Biotech (NASDAQ:EVAX) stock moved upwards by 157.5% to $16.74 during Thursday's regular session. Evaxion Biotech's stock is trading at a volume of...

Via Benzinga

55 Stocks Moving In Thursday's Mid-Day Session ↗

November 04, 2021

Gainers Evaxion Biotech A/S (NASDAQ: EVAX) shares climbed 179% to $18.17 after dropping over 10% on Wednesday. NerdWallet, Inc. (NASDAQ: NRDS) jumped 60% to $28.86 after the...

Via Benzinga

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

36 37 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.